当前位置:首页 - 行情中心 - 鱼跃医疗(002223) - 财务分析

鱼跃医疗

(002223)

  

流通市值:264.60亿  总市值:281.50亿
流通股本:9.42亿   总股本:10.02亿

鱼跃医疗(002223)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润4.29亿元,每股收益0.43元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1376395.21万元,未分配利润1012354.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1688923.53万元,负债312528.33万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,370,366,154.187,955,022,614.766,544,895,742.684,658,967,431.03
营业总成本1,866,982,526.486,616,589,598.15,187,824,391.823,579,183,683.09
其他经营收益
营业利润501,292,7291,700,320,952.341,685,030,326.081,386,867,012.99
利润总额501,402,173.471,684,492,195.651,684,332,877.451,387,100,427.73
净利润429,211,239.021,484,136,250.871,466,298,649.791,199,667,055.45
每股收益
其他综合收益-21,770,602.6398,208,788.57-25,254,882.74-42,485,052.57
综合收益总额407,440,636.391,582,345,039.441,441,043,767.051,157,182,002.88
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,633,656,957.53,797,199,703.3510,223,791,620.8510,064,100,218.05
非流动资产:
非流动资产合计10,255,578,377.0312,287,065,321.346,447,449,482.286,464,655,748.27
资产总计16,889,235,334.5316,084,265,024.6916,671,241,103.1316,528,755,966.32
流动负债:
流动负债合计2,825,540,893.992,458,668,934.672,768,309,795.862,834,995,169.99
非流动负债:
非流动负债合计299,742,381.75270,390,583.16267,726,475.98273,556,915.68
负债合计3,125,283,275.742,729,059,517.833,036,036,271.843,108,552,085.67
所有者权益(或股东权益):
归属于母公司股东权益合计13,650,005,211.7813,240,967,251.9213,521,175,567.8113,300,486,530.71
股东权益合计13,763,952,058.7913,355,205,506.8613,635,204,831.2913,420,203,880.65
负债和股东权益合计16,889,235,334.5316,084,265,024.6916,671,241,103.1316,528,755,966.32
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,506,674,223.269,008,754,158.817,146,382,148.934,827,739,978.24
经营活动现金流出小计1,909,562,786.797,505,832,443.025,642,881,477.483,660,879,300.9
经营活动产生的现金流量净额597,111,436.471,502,921,715.791,503,500,671.451,166,860,677.34
投资活动产生的现金流量:
投资活动现金流入小计8,280,162141,416,770.69140,748,706.07117,727,897.81
投资活动现金流出小计206,623,653.996,793,439,139.87373,222,771.81258,166,461.59
投资活动产生的现金流量净额-198,343,491.99-6,652,022,369.18-232,474,065.74-140,438,563.78
筹资活动产生的现金流量:
筹资活动现金流入小计5,336,538.8-9,701,657.19,701,657.1
筹资活动现金流出小计7,367,804.14821,817,705.99412,423,212.99406,943,868.74
筹资活动产生的现金流量净额-2,031,265.34-821,817,705.99-402,721,555.89-397,242,211.64
汇率变动对现金及现金等价物的影响-34,154,362.67-51,975,920.09-21,220,102.32-12,673,315.72
现金及现金等价物净增加额362,582,316.47-6,022,894,279.47847,084,947.5616,506,586.2
期末现金及现金等价物余额935,686,445.92573,104,129.457,443,083,356.427,212,504,995.12
补充资料:
现金及现金等价物的净增加额--6,022,894,279.47-616,506,586.2
最新报告期:2026-05-15
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华源证券刘闯1.601.802.072026-05-15
兴业证券孙媛媛,董晓洁,黄翰漾1.631.862.152026-05-12
长江证券彭英骐,徐晓欣1.752.192.642026-05-10
浙商证券王班,司清蕊1.601.852.172026-05-08
野村东方国际证券孔令岩,朱小溪1.691.972.242026-05-08
TOP↑